Entero Healthcare Solutions Limited IPO
₹1195 - ₹1258
11
1.53
| Open Date: | 09-Feb-2024 |
| Close Date: | 13-Feb-2024 |
| Allotment Date: | 14-Feb-2024 |
| Listing Date: | 16-Feb-2024 |
| Listing Price: | N/A |
| Face Value: | ₹10 Per Equity Share |
| Issue Price: | ₹1195-1258 Per Equity Share |
| Issue Size: | Total Issue Size 12,718,600 shares (aggregating up to ₹1,600.00 Cr) : Fresh Issue 7,949,125 shares (aggregating up to ₹1,000.00 Cr) : Offer for Sale 4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr) |
| Market Lot (Min Amount): | Retail - ₹13,838 : S-HNI - ₹207,570 : B-HNI - ₹1,010,174 |
As on | QIB | Nll | Rll | EMP | Total |
|---|---|---|---|---|---|
| Shares Offered/Reserved | 3,808,069 | 1,960,609 | 1,307,073 | 74,349 | 7,150,100 |
| Day 1 - 09-02-24 05:00 PM | 0.00x | 0.04x | 0.32x | 0.36x | 0.09x |
| Day 2 - 12-02-24 05:00 PM | 0.00x | 0.09x | 0.62x | 0.83x | 0.18x |
| Day 3 - 13-02-24 05:00 PM | 2.28x | 0.22x | 1.33x | 1.25x | 1.53x |
| Total No. of Application: | 129,800 (Approx.) | ||||
| Retail Subscription on the basis of Apps: | 1.13x | ||||
| Earning Per Share(EPS) | ₹N/A/- |
| P/E Ratio | N/A |
| RoNW | -1.86% |
| Net Asset Value (NAV) - Post Issue: | ₹N/A/- |
| Total Assets | Total Revenue | Profit After Tax | |
|---|---|---|---|
| 31 Sep,2023 | 1,505.95 | 1,898.98 | 11.64 |
| 31 Mar,2023 | 1,308.73 | 3,305.72 | -11.10 |
| 31 Mar,2022 | 1,125.98 | 2,526.55 | -29.44 |
| 31 Mar,2021 | 833.79 | 1,783.67 | -15.35 |
| Pre Issue Share Holding | 77.11% |
| Post Issue Share Holding | N/A% |
| 1. Prabhat Agrawal |
| 2. Prem Sethi |
| 3. OrbiMed Asia III Mauritius Limited. |
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment/prepayment, in full or part, of certain borrowings availed of by the company and our Subsidiaries.
- Funding the long term working capital requirements.
- Pursuing inorganic growth initiatives through acquisitions.
- General corporate purposes.
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.
Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.
The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a total of 3014 people in various departments.
No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.
If you are agree with app tems and condition to use the app.
Thank you.